Medivators Reprocessing Systems, a Minntech Corporation business group, announces it has received FDA 510(k) clearance of the Medivators DSD Edge automated endoscope reprocessor for the high-level disinfection of flexible, heat-sensitive endoscopes.
The Medivators DSD Edge is a dual-basin, asynchronous automated endoscope reprocessor designed for use in busy hospitals and endoscopy centers. Based on the popular and easy-to-use Medivators DSD-201, the Medivators DSD Edge is designed to provide the fastest endoscope turn-around time in the United States with a reprocessing cycle as short as 22 minutes.
The DSD Edge utilizes Rapicide® PA High Level Disinfectant, a single-use, environmentally responsible, endoscope-safe formulation. Rapicide PA is aldehyde-free, and is designed specifically to high-level disinfect at the low temperature of 30 degrees C, thus assuring excellent compatibility with all endoscope materials. Its user-friendly packaging and usage design reduce worker exposure for safer handling. The peracetic acid solution used during a DSD Edge reprocessing cycle does not have to be neutralized prior to disposal, as the breakdown products of peracetic acid are water, oxygen, and acetic acid.
Other standard features of the DSD Edge include: automated leak testing to minimize leak-related repair costs, a final alcohol purge to facilitate drying of endoscope channels, and an optional supplemental wash cycle using Intercept Detergent provides for additional and consistent cleaning of the endoscope. An optional data management system for cycle tracking and record keeping is also available.
Paul Harding, Medivators general manager, stated, “Lengthy endoscope reprocessing cycle times can lead to procedure bottlenecks. We recognize the need for patient safety along with quicker endoscope turnaround times that result in not only increased procedures and more efficient utilization of endoscope inventory, but also the very positive financial impact this can have on the unit’s operating budget."
Invisible, Indispensable: The Vital Role of AHRQ in Infection Prevention
March 25th 2025With health care systems under strain and infection preventionists being laid off nationwide, a little-known federal agency stands as a last line of defense against preventable patient harm. Yet the Agency for Healthcare Research and Quality (AHRQ) is now facing devastating cuts—threatening decades of progress in patient safety.
The Sterile Processing Conference Survival Guide: How to Make the Most of Your Next Event
March 25th 2025From expert speakers to cutting-edge tools, sterile processing conferences, like the 2025 HSPA Annual Conference and the SoCal SPA's Spring Conference, offer unmatched opportunities to grow your skills, expand your network, and strengthen your department's infection prevention game.
Redefining Material Compatibility in Sterilization: Insights From AAMI TIR17:2024
March 24th 2025AAMI TIR17:2024 provides updated, evidence-based guidance on material compatibility with sterilization modalities. It offers essential insights for medical device design and ensures safety without compromising functionality.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.
Unmasking Long COVID: Dr Noah Greenspan on Recovery, Research Gaps, and the Future of Treatment
March 18th 2025Dr Noah Greenspan discusses the evolving understanding of long COVID, current treatment strategies, diagnostic challenges, and the critical need for research and awareness in post-viral syndromes.